Vodudeutentan

N/A

Report date: 2025/01/02 16:12:19
NMEFirst In Class

Base Information

Drug NameVodudeutentan
Drug Alias NameENB-003ENB-006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnb Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnb Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsPancreatic Neoplasms +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A